METiS Therapeutics Company
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Investors
Industry:
AI, Early Drug Development, United States
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2017-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
11
Total Funding:
176215374
Last Funding Date:
2022-04-05
Last Funding Type:
Series B
Register and Claim Ownership